Tag: CDMO
Lonza to acquire Genentech’s biologics manufacturing facility in Vacaville for $1.2bn
In a strategic move that significantly escalates its capacity in the biologics manufacturing landscape, Lonza, a key global player in manufacturing for the pharmaceutical, biotech, ... Read More
Oxford Biomedica to acquire ABL Europe to expand global CDMO reach
Oxford Biomedica plc, a leading cell and gene therapy Contract Development and Manufacturing Organization (CDMO), is set to significantly enhance its global presence with the ... Read More
Indian CDMO Gland Pharma to acquire French CDMO Cenexi
Gland Pharma, an Indian contract development and manufacturing organization (CDMO), through its Singapore subsidiary Gland Pharma International, has agreed to acquire Cenexi, a French CDMO, ... Read More
Jubilant Ingrevia bags CDMO contract worth Rs 270cr
Jubilant Ingrevia, an Indian chemicals company, has bagged a contract development and manufacturing company (CDMO) contract with an estimated value of INR 270 crores for ... Read More
Windlas Biotech clears EU GMP inspection for Dehradun plant
Windlas Biotech has cleared a GMP inspection of the European Union (EU) done by the National Institute of Pharmacy and Nutrition, Hungary for its plant-IV ... Read More
Merck to acquire US biopharma CDMO Exelead for $780m
Pharma giant Merck has signed an all-cash deal worth around $780 million to acquire Exelead, an Indiana-based biopharmaceutical contract development and manufacturing organization (biopharma CDMO). ... Read More
Philip Morris wraps up $820m acquisition of Danish CDMO Fertin Pharma
Philip Morris International (PMI) has wrapped up its previously announced DKK 5.1 billion ($820 million) acquisition of Fertin Pharma, a Danish a specialist contract development ... Read More
Cipla to form respiratory biosimilars JV with Indian CDMO Kemwell Biopharma
Cipla Limited has entered into a joint venture (JV) agreement with Kemwell Biopharma, a Bengaluru-based biopharma contract development and manufacturing organization (CDMO), for developing, manufacturing, ... Read More
Partners Group to acquire majority stake in European CDMO Pharmathen
Swiss private equity firm Partners Group has agreed on behalf of its clients to acquire a majority stake in Pharmathen, a Netherlands-based pharma company, from ... Read More
Danaher to acquire US CDMO Aldevron for $9.6bn
Danaher Corporation has agreed to acquire Aldevron, a North Dakota-based manufacturer of plasmid DNA, mRNA, and recombinant proteins, for nearly $9.6 billion from EQT Group’s ... Read More